To read the full story, subscribe or sign in.

Celgene seeks FDA approval for clinical trials with thalidomide for autoimmune disorders

Sep. 29, 1997

No Comments

BioWorld Science Regulatory Musculoskeletal

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 11, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

BioWorld Science

In a presentation at the recent American Society of Hematology meeting in San Diego, Kite Pharma Inc. reported preclinical data for KITE-753, an autologous rapid...

Boryung invests $10M in Intuitive Machines for outer space R&D

BioWorld

Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...

Upgrade your daily dose of biopharma and medtech news

Celgene seeks FDA approval for clinical trials with thalidomide for autoimmune disorders